Nektar Therapeutics

Develops polymer-based medicines for autoimmune and inflammatory diseases.

Founded 1990 · 61 employees · United States · Public

Listed:

NASDAQ: NKTR

Subsidiaries:

Nektar Therapeutics (India) Private Limited